|Articles|June 22, 2021
Operational Impact of Annex 1 Update v2
Author(s)Veltek Associates, Inc.
The update for EU annex 1 is more than a simple revision, solidifying the expectation that facility fully understand their processes and systems.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
2
Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care
3
New Targets for Clinical Trials in the European Union
4
Leveraging AI/ML to Reduce Risk in Drug Development: Part One
5
